Contract 75N93021C00017
Emory University · Department Of Health And Human Services · July 16, 2024
Emory University was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 16, 2024 for $8.82 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Atlanta, GA. It was awarded under full and open competition. The contract has been modified 8 times since the base award It uses cost no fee contract pricing. The most recent modification was on March 25, 2026. If all options are exercised, the contract could reach $79.30 million.
Contract details
- PIID
- 75N93021C00017
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Atlanta, GA
- First action
- July 16, 2024
- Latest action
- March 25, 2026
Description
EMORY CEIRR - THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR).
Modification timeline
-
March 25, 2026Mod P00024 · Exercise An Option$29.88M
-
December 30, 2025Mod P00023 · Exercise An Option$29.43M
-
September 22, 2025Mod P00022 · Exercise An Option$28.31M
-
September 18, 2025Mod P00021 · Exercise An Option$27.48M
-
July 31, 2025Mod P00020 · Exercise An Option$26.23M
-
June 26, 2025Mod P00019 · Supplemental Agreement For Work Within Scope$25.93M
-
September 19, 2024Mod P00016 · Funding Only Action$22.52M
-
July 23, 2024Mod P00015 · Exercise An Option$19.35M
-
July 16, 2024Mod P00014 · Supplemental Agreement For Work Within Scope$17.64M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $20.43M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| The Brain Donor Project, Inc | Department Of Health And Human Services | April 1, 2026 | $1.27M |
| Lovelace Biomedical Research Institute | Department Of Health And Human Services | April 1, 2026 | $680.2K |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93021C00017?
Contract 75N93021C00017 is a federal contract awarded to Emory University by Department Of Health And Human Services on July 16, 2024 for $8.82 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 8 times since the base award.
Who won contract 75N93021C00017?
Emory University won contract 75N93021C00017 from Department Of Health And Human Services.
How much is contract 75N93021C00017 worth?
Contract 75N93021C00017 has obligated $8.82 million to date, with a total potential value of $79.30 million if all options are exercised.